Cargando…

Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer

BACKGROUND: The correlation between tumor markers (TM) and TNM stage of non-small-cell lung cancer (NSCLC) has not been widely reported. METHODS: TM levels (CEA, CA125, CA15-3, CA19-9, CA72-4, CYFRA21-1, and SCC-Ag) in 424 cases of lung adenocarcinoma (LAC), 166 cases of lung squamous cell carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhong-qing, Huang, Ling-sha, Zhu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311751/ https://www.ncbi.nlm.nih.gov/pubmed/30647803 http://dx.doi.org/10.1155/2018/9845123

Ejemplares similares

Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?
por: Plebani, M., et al.
Publicado: (1995)

Comparison of Serum MicroRNA21 and Tumor Markers in Diagnosis of Early Non-Small Cell Lung Cancer
por: Sun, Mingzhong, et al.
Publicado: (2016)

Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer
por: Jiang, Sha-Sha, et al.
Publicado: (2021)

Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer
por: Hur, Jin, et al.
Publicado: (2012)

Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer
por: Mu, Yinyu, et al.
Publicado: (2020)

The role of seven autoantibodies in lung cancer diagnosis
por: Luo, Bin, et al.
Publicado: (2021)

Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer
por: Ren, Sai, et al.
Publicado: (2023)

Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China
por: Abbas, Muhammad, et al.
Publicado: (2020)

Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer
por: ZHAO, YANGXING, et al.
Publicado: (2013)

Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer
por: Li, Yang, et al.
Publicado: (2019)

Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer
por: Duan, Guo-Chen, et al.
Publicado: (2020)

A Multi-Omics Network of a Seven-Gene Prognostic Signature for Non-Small Cell Lung Cancer
por: Ye, Qing, et al.
Publicado: (2021)

Machine Learning-Assisted Dual-Marker Detection in Serum Small Extracellular Vesicles for the Diagnosis and Prognosis Prediction of Non-Small Cell Lung Cancer
por: Li, Wenzhe, et al.
Publicado: (2022)

Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
por: Fang, Xiaoxu, et al.
Publicado: (2022)

Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions
por: Miédougé, M, et al.
Publicado: (1999)

Seven tumor‐associated autoantibodies as a serum biomarker for primary screening of early‐stage non‐small cell lung cancer
por: Chen, Ping, et al.
Publicado: (2021)

Evaluation of VEGF-C and Tumor Markers in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis
por: Cao, Chao, et al.
Publicado: (2013)

The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer
por: Jiang, Chunyang, et al.
Publicado: (2022)

Clinical application of biological markers for treatments of resectable non-small-cell lung cancers
por: Huang, C, et al.
Publicado: (2005)

Identification of seven tumor‐educated platelets RNAs for cancer diagnosis
por: Ge, Xinxin, et al.
Publicado: (2021)

Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer
por: Dai, Nan, et al.
Publicado: (2013)

Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer
por: Lai, Yanzhen, et al.
Publicado: (2018)

Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer
por: Zhang, Chuantao, et al.
Publicado: (2021)

Correlation of cancer stem cell markers and immune cell markers in resected non-small cell lung cancer
por: Huang, Zhaoqin, et al.
Publicado: (2017)

Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases
por: Omi, Makiko, et al.
Publicado: (2020)

The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer
por: Liu, Linjie, et al.
Publicado: (2017)

The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis
por: Guo, Sumin, et al.
Publicado: (2023)

The clinical value of circulating tumor DNA detection in advanced non-small cell lung cancer
por: Lin, Xiao, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy Is Effective in Modifying the Tumor Genome and Tumor Immune Microenvironment in Non-Small Cell Lung Cancer or Lung Metastatic Carcinoma
por: Zhou, Pu, et al.
Publicado: (2021)

Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis
por: Zhang, Wei, et al.
Publicado: (2022)

Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer
por: Chorostowska-Wynimko, J, et al.
Publicado: (2009)

The relationship of plasma fibrinogen with clinicopathological stages and tumor markers in patients with non-small cell lung cancer
por: Bian, Nan-Nan, et al.
Publicado: (2019)

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer
por: Shen, Qinglin, et al.
Publicado: (2023)

Apolipoproteins as Differentiating and Predictive Markers for Assessing Clinical Outcomes in Patients with Small Cell Lung Cancer
por: Shi, Jian, et al.
Publicado: (2016)

Clinical and molecular characterization of seven patients with Danon disease
por: Wang, Xuan-Ying, et al.
Publicado: (2021)

Assessment of Serum Tumor Markers for Predicting Ocular Metastasis in Lung Adenocarcinoma: A Retrospective Study
por: Shi, Wen-Qing, et al.
Publicado: (2020)

Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer.
por: Pujol, J. L., et al.
Publicado: (1993)

A novel technology to integrate imaging and clinical markers for non-invasive diagnosis of lung cancer
por: Shaffie, Ahmed, et al.
Publicado: (2021)

Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer
por: Li, Ling, et al.
Publicado: (2016)

Urinary N(1), N(12)-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer
por: Takahashi, Yusuke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gusini412amfs4v4dcbaj5k2mo